These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27542784)

  • 1. Implantation of bioresorbable vascular scaffolds following acute coronary syndrome is associated with reduced early neointimal growth and strut coverage.
    Giblett JP; Brown AJ; Keevil H; Jaworski C; Hoole SP; West NE
    EuroIntervention; 2016 Aug; 12(6):724-33. PubMed ID: 27542784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
    Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P
    Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Clinical Presentation on Early Vascular Healing After Bioresorbable Vascular Scaffold Implantation.
    Baquet M; Brenner C; Wenzler M; Eickhoff M; David J; Brunner S; Theiss H; Massberg S; Guagliumi G; Mehilli J
    J Interv Cardiol; 2017 Feb; 30(1):16-23. PubMed ID: 27896843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography-guided versus angiography-guided implantation of everolimus-eluting bioresorbable vascular scaffolds: Comparison of coverage, apposition and clinical outcome. The ALSTER-OCT ABSORB registry.
    Heeger CH; Schedifka AS; Meincke F; Spangenberg T; Wienemann H; Kreidel F; Kuck KH; Ghanem A; Bergmann MW
    Cardiol J; 2018; 25(4):459-469. PubMed ID: 29512092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.
    Bourantas CV; Papafaklis MI; Kotsia A; Farooq V; Muramatsu T; Gomez-Lara J; Zhang YJ; Iqbal J; Kalatzis FG; Naka KK; Fotiadis DI; Dorange C; Wang J; Rapoza R; Garcia-Garcia HM; Onuma Y; Michalis LK; Serruys PW
    JACC Cardiovasc Interv; 2014 Mar; 7(3):315-24. PubMed ID: 24529931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.
    Gutiérrez-Chico JL; Gijsen F; Regar E; Wentzel J; de Bruyne B; Thuesen L; Ormiston J; McClean DR; Windecker S; Chevalier B; Dudek D; Whitbourn R; Brugaletta S; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2012 Apr; 5(4):428-35. PubMed ID: 22516401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
    Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
    EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
    Gomez-Lara J; Brugaletta S; Diletti R; Garg S; Onuma Y; Gogas BD; van Geuns RJ; Dorange C; Veldhof S; Rapoza R; Whitbourn R; Windecker S; Garcia-Garcia HM; Regar E; Serruys PW
    Eur Heart J; 2011 Feb; 32(3):294-304. PubMed ID: 21123276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms.
    Gori T; Jansen T; Weissner M; Foin N; Wenzel P; Schulz E; Cook S; Münzel T
    Eur Heart J; 2016 Jul; 37(26):2040-9. PubMed ID: 26543048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between peri-strut low intensity areas and vascular healing response after everolimus-eluting bioresorbable scaffold implantation: An optical coherence tomography study.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    J Cardiol; 2017 Apr; 69(4):606-612. PubMed ID: 27520757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis.
    Sheehy A; Gutiérrez-Chico JL; Diletti R; Oberhauser JP; Glauser T; Harrington J; Kossuth MB; Rapoza RJ; Onuma Y; Serruys PW
    EuroIntervention; 2012 Feb; 7(10):1227-35. PubMed ID: 22222916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.
    Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies.
    Gogas BD; Radu M; Onuma Y; Perkins L; Powers JC; Gomez-Lara J; Farooq V; Garcia-Garcia HM; Diletti R; Rapoza R; Virmani R; Serruys PW
    Int J Cardiovasc Imaging; 2012 Mar; 28(3):499-511. PubMed ID: 21503708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model.
    Tenekecioglu E; Torii R; Bourantas C; Abdelghani M; Cavalcante R; Sotomi Y; Crake T; Su S; Santoso T; Onuma Y; Serruys PW
    Int J Cardiol; 2017 Jan; 227():467-473. PubMed ID: 27839816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are BVS suitable for ACS patients? Support from a large single center real live registry.
    Felix CM; Onuma Y; Fam JM; Diletti R; Ishibashi Y; Karanasos A; Everaert BRC; van Mieghem NMDA; Daemen J; de Jaegere PPT; Zijlstra F; Regar ES; van Geuns RJM
    Int J Cardiol; 2016 Sep; 218():89-97. PubMed ID: 27232918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.